These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
17. Selective A2A adenosine agonist ATL-146e attenuates acute lethal liver injury in mice. Odashima M, Otaka M, Jin M, Komatsu K, Wada I, Matsuhashi T, Horikawa Y, Hatakeyama N, Oyake J, Ohba R, Linden J, Watanabe S. J Gastroenterol; 2005 May 08; 40(5):526-9. PubMed ID: 15942719 [Abstract] [Full Text] [Related]
18. Reduction in myocardial infarct size at 48 hours after brief intravenous infusion of ATL-146e, a highly selective adenosine A2A receptor agonist. Patel RA, Glover DK, Broisat A, Kabul HK, Ruiz M, Goodman NC, Kramer CM, Meerdink DJ, Linden J, Beller GA. Am J Physiol Heart Circ Physiol; 2009 Aug 08; 297(2):H637-42. PubMed ID: 19502555 [Abstract] [Full Text] [Related]
19. Activation of A2A adenosine receptor attenuates intestinal inflammation in animal models of inflammatory bowel disease. Odashima M, Bamias G, Rivera-Nieves J, Linden J, Nast CC, Moskaluk CA, Marini M, Sugawara K, Kozaiwa K, Otaka M, Watanabe S, Cominelli F. Gastroenterology; 2005 Jul 08; 129(1):26-33. PubMed ID: 16012931 [Abstract] [Full Text] [Related]